|
Market Closed -
Toronto S.E.
01:30:00 16/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.600 CAD | 0.00% |
|
-13.51% | +22.14% |
Company Valuation: Cardiol Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 142 | 43.96 | 71.77 | 151 | 130.4 | 186.9 | - | - |
| Change | - | -69.05% | 63.28% | 110.34% | -13.65% | 43.38% | - | - |
| Enterprise Value (EV) 1 | 142 | 43.96 | 36.84 | 120.4 | 108.9 | 167.9 | 180.3 | 186.9 |
| Change | - | -69.05% | -16.19% | 226.78% | -9.5% | 54.08% | 7.42% | 3.66% |
| P/E | -3.19x | -1.41x | -2.5x | -3.63x | -3.36x | -3.33x | -5.45x | -23.4x |
| PBR | - | - | 2.55x | 6.18x | 6.41x | 7.11x | 50x | - |
| PEG | - | 0x | 0.2x | -0.2x | 0.1x | -0.1x | 0.1x | 0.3x |
| Capitalization / Revenue | 1,803x | - | - | - | - | - | 112x | 3.54x |
| EV / Revenue | 1,803x | - | - | - | - | - | 108x | 3.54x |
| EV / EBITDA | -4.74x | -1.07x | -1.25x | -3x | -3.18x | -4.68x | -8.87x | -9.07x |
| EV / EBIT | -3.67x | -1.06x | -1.24x | -2.99x | -3.17x | -4.6x | -4.94x | -29.7x |
| EV / FCF | -6.03x | - | -1.46x | -4.8x | -4.56x | -5.39x | -5.77x | -2.89x |
| FCF Yield | -16.6% | - | -68.5% | -20.8% | -21.9% | -18.5% | -17.3% | -34.6% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.73 | -0.49 | -0.44 | -0.51 | -0.39 | -0.4804 | -0.2934 | -0.0685 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.0788 | - | - | - | - | - | 1.667 | 52.75 |
| EBITDA 1 | -29.95 | -41.12 | -29.54 | -40.11 | -34.21 | -35.9 | -20.34 | -20.62 |
| EBIT 1 | -38.66 | -41.34 | -29.79 | -40.28 | -34.32 | -36.49 | -36.54 | -6.288 |
| Net income 1 | -31.64 | -30.93 | -28.13 | -36.68 | -33.82 | -36.11 | -37.94 | -15.29 |
| Net Debt 1 | - | - | -34.93 | -30.58 | -21.42 | -19.05 | -6.594 | - |
| Reference price 2 | 2.330 | 0.690 | 1.100 | 1.850 | 1.310 | 1.600 | 1.600 | 1.600 |
| Nbr of stocks (in thousands) | 60,954 | 63,703 | 65,247 | 81,603 | 99,514 | 1,16,823 | - | - |
| Announcement Date | 23/03/22 | 28/03/23 | 01/04/24 | 31/03/25 | 31/03/26 | - | - | - |
1CAD in Million2CAD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.33x | - | -4.68x | - | 13Cr | |
| 20.07x | 7.14x | 14.31x | 1.48% | 6.9TCr | |
| 28.61x | 7.85x | 24.63x | 0.05% | 5.31TCr | |
| 35.29x | 6.26x | 18.73x | 0.92% | 5.08TCr | |
| 34.21x | 3.36x | 14.49x | -.--% | 4.46TCr | |
| -19.62x | 197.94x | -20.83x | -.--% | 4.06TCr | |
| 49.56x | 5.68x | 31.19x | -.--% | 4.25TCr | |
| 27.19x | 7.72x | 19.99x | 0.39% | 3.09TCr | |
| 29.37x | 6.23x | 16.17x | -.--% | 2.54TCr | |
| -13.66x | 5.14x | -6.23x | -.--% | 2.27TCr | |
| Average | 18.77x | 27.48x | 10.78x | 0.32% | 3.8TCr | |
| Weighted average by Cap. | 23.21x | 26.76x | 13.86x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CRDL Stock
- Valuation Cardiol Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
